Ligand Pharmaceuticals Inc $13,352,856 Viking Therapeutics, Inc. $5,648,163 Qualigen Therapeutics Inc $60,999 OmniAb, Inc $13,568,856 Ligand Pharmaceuticals Inc $13,352,856 Viking Therapeutics, Inc. $5,648,163 Qualigen Therapeutics Inc $60,999 OmniAb, Inc $13,568,856